Barinthus Biotherapeutics plc. — Investor Relations & Filings
Barinthus Biotherapeutics plc is a clinical-stage biopharmaceutical company that develops novel immunotherapies designed to guide T cells to control disease. The company is advancing a new generation of antigen-specific immunotherapeutics for treating autoimmunity, chronic infectious diseases, and cancer. Its therapeutic approach focuses on creating candidates that can overcome these conditions by modulating the body's T cell response. The development pipeline includes programs targeting various indications, with a strategic focus on immunology and inflammatory diseases.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| FORM 8-K | 2026-05-21 | English | |
| 10-Q - Barinthus Biotherapeutics plc. (0001828185) (Filer) | 2026-04-30 | English | |
| 8-K - Barinthus Biotherapeutics plc. (0001828185) (Filer) | 2026-04-30 | English | |
| 8-K - Barinthus Biotherapeutics plc. (0001828185) (Filer) | 2026-04-22 | English | |
| 8-K - Barinthus Biotherapeutics plc. (0001828185) (Filer) | 2026-02-23 | English | |
| 8-K | 2026-01-06 | English |
Browse filings by year
7 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
6 filings
| |||||
| 46726643 | FORM 8-K | 2026-05-21 | English | ||
| 39074800 | 10-Q - Barinthus Biotherapeutics plc. (0001828185) (Filer) | 2026-04-30 | English | ||
| 39072782 | 8-K - Barinthus Biotherapeutics plc. (0001828185) (Filer) | 2026-04-30 | English | ||
| 35399458 | 8-K - Barinthus Biotherapeutics plc. (0001828185) (Filer) | 2026-04-22 | English | ||
| 32826299 | 8-K - Barinthus Biotherapeutics plc. (0001828185) (Filer) | 2026-02-23 | English | ||
| 13323828 | 8-K | 2026-01-06 | English | ||
|
2025
9 filings
| |||||
| 13323834 | 8-K | 2025-12-10 | English | ||
| 13323802 | 10-Q | 2025-11-07 | English | ||
| 13323835 | 8-K | 2025-11-07 | English | ||
| 13323803 | FORM 8-K | 2025-09-30 | English | ||
| 31941198 | 425 Filing | 2025-09-30 | English | ||
| 31941195 | 425 Filing | 2025-09-30 | English | ||
| 13323832 | FORM 8-K/A | 2025-08-08 | English | ||
| 13323804 | 10-Q | 2025-08-07 | English | ||
| 13323808 | 8-K | 2025-08-07 | English | ||
Financials
We couldn't load the financials
No data available yet
We have extracted financials for Barinthus Biotherapeutics plc., but not for this combination of statement and period. Try a different combination.
Swipe the table to view all periods, or rotate your phone for a wider view.
| Line item | ! |
|---|---|
| Definition not yet available — coming soon. |
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
13260917 Canada Inc.
Biotech developing oral small molecules to restore muscle s…
|
MSCL | CA | Manufacturing |
|
1608557 Ontario Inc.
Biopharmaceutical company dedicated to R&D, discovery, and …
|
OTROQ | CA | Manufacturing |
|
3B BlackBio Dx Limited
Develops molecular diagnostic kits for oncology, infectious…
|
3BBLACKBIO | IN | Manufacturing |
|
3D Medicines Inc.
Commercial-stage biopharma specializing in next-generation …
|
1244 | HK | Manufacturing |
|
3SBio Inc.
Biopharmaceutical enterprise specializing in R&D, productio…
|
1530 | KY | Manufacturing |
|
4BASEBIO PLC
Manufactures GMP-grade synthetic DNA for next-generation th…
|
4BB | GB | Manufacturing |
|
4D Molecular Therapeutics, Inc.
Develops genetic medicines using AAV vectors for ophthalmol…
|
FDMT | US | Manufacturing |
|
4Front Ventures Corp.
Vertically integrated cannabis operator managing cultivatio…
|
FFNT | CA | Manufacturing |
|
4SC AG
Biopharmaceutical company with no products under developmen…
|
VSC | DE | Manufacturing |
|
60 DEGREES PHARMACEUTICALS, INC.
Develops and commercializes medicines for infectious diseas…
|
SXTP | US | Manufacturing |
Barinthus Biotherapeutics plc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/34488/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=34488 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=34488 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=34488 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 34488}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Barinthus Biotherapeutics plc. (id: 34488)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.